Literature DB >> 12136917

Autoantibodies to NOR 90/hUBF: longterm clinical and serological followup in a patient with limited systemic sclerosis suggests an antigen driven immune response.

Jehan H Dagher1, Ulrich Scheer, Renate Voit, Ingrid Grummt, Lilian Lonzetti, Yves Raymond, Jean-Luc Senécal.   

Abstract

We describe the clinical and serological followup of a 9-year-old girl with anti-nucleolar organizing region 90/human upstream-binding factor (anti-NOR 90/hUBF) who had features of systemic sclerosis over a period of 17 years, from childhood into adulthood. We review the associations of anti-UBF autoantibodies, and provide evidence that anti-NOR 90/UBF immune response is antigen driven.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12136917

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

1.  Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers.

Authors:  Ilaria Cavazzana; Tamara Vojinovic; Paolo Airo'; Micaela Fredi; Angela Ceribelli; Eleonora Pedretti; Maria Grazia Lazzaroni; Emirena Garrafa; Franco Franceschini
Journal:  Clin Rev Allergy Immunol       Date:  2022-06-18       Impact factor: 8.667

Review 2.  Anti-nuclear autoantibodies in systemic sclerosis : News and perspectives.

Authors:  Yasuhito Hamaguchi; Kazuhiko Takehara
Journal:  J Scleroderma Relat Disord       Date:  2018-07-10

Review 3.  Clinical Significance of Antinucleolar Antibodies: Biomarkers for Autoimmune Diseases, Malignancies, and others.

Authors:  Minoru Satoh; Angela Ceribelli; Tomoko Hasegawa; Shin Tanaka
Journal:  Clin Rev Allergy Immunol       Date:  2022-03-08       Impact factor: 10.817

4.  Thrombotic Microangiopathy Secondary to Systemic Sclerosis with Severe Complement Activation Not Responsive to Eculizumab: A Case Report.

Authors:  Masahiko Nakamura; Tomohiro Abe; Hidenobu Ochiai
Journal:  Am J Case Rep       Date:  2022-06-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.